MedaRed snags $6.5 mln seed
MedaRed Inc, a biotechnology company focused on discovering and developing new therapeutics targeting fibrin, has raised $6.5 million in seed financing. The lead investors were Dementia Discovery Fund and Dolby Family Ventures.
8 July 2019•1 min read
